Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Conversion from twice-daily tacrolimus to once-daily extended-release tacrolimus in lung transplant patients
2009-014050-15Phase 4Completed
- Sponsor
- Erasmus Hospital
- Start
- Sep 2009
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tacrolimus in cystic fibrosis (CF) (2 arms), sponsored by Erasmus Hospital. Primary endpoints: Pharmacokinetic parameters of tacrolimus and Intra-individual reproducibility of pharmacokinetic data. Started Sep 2009; status: completed.
02
Drugs
tacrolimus
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on 2009-014050-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014050-15.